Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, SMS Pharmaceuticals has informed that it enclosed a copy of investor presentation of the Company for the fourth Quarter and financial year ended 31st March, 2022. This Investor Presentation may also be accessed on the website of the Company at www.smspharma.com.
The above information is a part of company’s filings submitted to BSE.